D. E. Shaw & Co., Inc. Sangamo Therapeutics, Inc Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 3,067,435 shares of SGMO stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,067,435

Previous 4,683,973 34.51%

Holding current value

$1.38 Million

Previous $2.53 Million 18.74%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.42 - $1.38 $678,945 - $2.23 Million	-1,616,538 Reduced 34.51%	3,067,435 $2.06 Million
Q4 2023 Feb 14, 2024	BUY	$0.3 - $0.63 $652,616 - $1.37 Million	2,175,388 Added 86.72%	4,683,973 $2.53 Million
Q3 2023 Nov 14, 2023	BUY	$0.58 - $1.47 $72,273 - $183,175	124,609 Added 5.23%	2,508,585 $1.51 Million
Q2 2023 Aug 14, 2023	BUY	$1.11 - $1.74 $655,775 - $1.03 Million	590,789 Added 32.95%	2,383,976 $3.1 Million
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $692,814 - $1.53 Million	417,358 Added 30.34%	1,793,187 $3.16 Million

Q4 2022 Feb 14, 2023	BUY	$2.77 - $5.07 $474,215 - $867,968	171,197 Added 14.21%	1,375,829 $4.32 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $206,676 - $309,288	48,402 Added 4.19%	1,204,632 $5.9 Million
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $1.32 Million - $2.49 Million	401,463 Added 53.19%	1,156,230 $4.79 Million
Q1 2022 May 16, 2022	BUY	$5.23 - $7.82 $1.05 Million - $1.56 Million	200,022 Added 36.06%	754,767 $4.39 Million
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $3.74 Million - $5.63 Million	512,831 Added 1223.53%	554,745 $4.16 Million
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $155,593 - $207,400	17,269 Added 70.07%	41,914 $378,000
Q2 2021 Aug 16, 2021	SELL	$10.17 - $12.64 $478,630 - $594,876	-47,063 Reduced 65.63%	24,645 $295,000
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $4.08 Million - $6.4 Million	-375,298 Reduced 83.96%	71,708 $899,000
Q4 2020 Feb 16, 2021	BUY	$9.23 - $18.18 $2.81 Million - $5.53 Million	303,994 Added 212.57%	447,006 $6.98 Million
Q3 2020 Nov 16, 2020	BUY	$9.38 - $12.48 $1.02 Million - $1.36 Million	108,797 Added 317.98%	143,012 $1.35 Million
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $141,022 - $268,647	22,709 Added 197.37%	34,215 $307,000
Q1 2020 May 15, 2020	SELL	$5.05 - $8.85 $848,748 - $1.49 Million	-168,069 Reduced 93.59%	11,506 $73,000
Q1 2019 May 15, 2019	SELL	$7.72 - $12.81 $687,952 - $1.14 Million	-89,113 Reduced 33.17%	179,575 $1.71 Million
Q4 2018 Feb 14, 2019	BUY	$9.51 - $16.6 $1.63 Million - $2.84 Million	170,876 Added 174.7%	268,688 $3.09 Million
Q3 2018 Nov 14, 2018	BUY	$13.05 - $19.05 $1.09 Million - $1.6 Million	83,806 Added 598.36%	97,812 $1.66 Million
Q2 2018 Aug 14, 2018	SELL	$13.9 - $19.8 $4.39 Million - $6.26 Million	-316,135 Reduced 95.76%	14,006 $199,000
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $17.3 Million - $27.2 Million	-1,034,154 Reduced 75.8%	330,141 $6.27 Million
Q4 2017 Feb 14, 2018	SELL	$11.6 - $17.35 $2.79 Million - $4.17 Million	-240,260 Reduced 14.97%	1,364,295 $22.4 Million
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $13.5 Million - $24.1 Million	1,604,555	1,604,555 $24.1 Million

Others Institutions Holding SGMO

# of Institutions

138

Shares Held

100M

Call Options Held

35.5K

Put Options Held

65.8K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $70.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account